Cristina
Bohorquez Heras
Profesor/a Asociado/a en CC. de la Salud
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaHospital de Gran Canaria Dr. Negrin -ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2024
-
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis
European Journal of Clinical Investigation, Vol. 54, Núm. 2
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
2022
2021
2020
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
-
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: Data from the RELESSER Registry
Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2043-2051
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
2017
-
Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)
Clinical and Experimental Rheumatology, Vol. 35, pp. 28-34
-
Juvenile- and adult-onset systemic lupus erythematosus: A comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Clinical and Experimental Rheumatology, Vol. 35, Núm. 6, pp. 1047-1055
2016
-
Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, pp. 40-47
2015
-
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640